These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Luo Y; Cao X; Pan Q; Li J; Feng J; Li F J Nucl Med; 2019 Dec; 60(12):1724-1729. PubMed ID: 31101745 [No Abstract] [Full Text] [Related]
12. [Clinical features of 16 cases of lymphoplasmacytic lymphoma/Waldenström macroglobulinemia]. Wang JJ; Jing HM; Shen HW; Xu JS; Li M; Gao ZF; Ke XY Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1494-8. PubMed ID: 21176358 [TBL] [Abstract][Full Text] [Related]
13. Patterns of survival in lymphoplasmacytic lymphoma/Waldenström macroglobulinemia: a population-based study of 1,555 patients diagnosed in Sweden from 1980 to 2005. Kristinsson SY; Eloranta S; Dickman PW; Andersson TM; Turesson I; Landgren O; Björkholm M Am J Hematol; 2013 Jan; 88(1):60-5. PubMed ID: 23165980 [TBL] [Abstract][Full Text] [Related]
14. Transformation to diffuse large B-cell lymphoma with germinal center B-cell like subtype and discordant light chain expression in a patient with Waldenström macroglobulinemia/lymphoplasmacytic lymphoma. Kobayashi H; Asada N; Egusa Y; Ikeda T; Sakamoto M; Abe M; Ennishi D; Sakata M; Takaki A; Kawahara S; Meguri Y; Nishimori H; Fujii N; Matsuoka KI; Sato Y; Yoshino T; Maeda Y Int J Hematol; 2021 Sep; 114(3):401-407. PubMed ID: 33907976 [TBL] [Abstract][Full Text] [Related]
15. Familial aggregation of lymphoplasmacytic lymphoma/Waldenström macroglobulinemia with solid tumors and myeloid malignancies. Kristinsson SY; Goldin LR; Turesson I; Björkholm M; Landgren O Acta Haematol; 2012; 127(3):173-7. PubMed ID: 22310551 [TBL] [Abstract][Full Text] [Related]
16. Elevated risk of venous but not arterial thrombosis in Waldenström macroglobulinemia/lymphoplasmacytic lymphoma. Hultcrantz M; Pfeiffer RM; Björkholm M; Goldin LR; Turesson I; Schulman S; Landgren O; Kristinsson SY J Thromb Haemost; 2014 Nov; 12(11):1816-21. PubMed ID: 25196979 [TBL] [Abstract][Full Text] [Related]
18. A matched case-control study comparing features, treatment and outcomes between patients with non-IgM lymphoplasmacytic lymphoma and Waldenström macroglobulinemia. Castillo JJ; Itchaki G; Gustine JN; Meid K; Flynn CA; Demos MG; Guerrera ML; Jimenez C; Kofides A; Liu X; Munshi M; Tsakmaklis N; Patterson CJ; Xu L; Yang G; Hunter ZR; Treon SP Leuk Lymphoma; 2020 Jun; 61(6):1388-1394. PubMed ID: 31992103 [TBL] [Abstract][Full Text] [Related]
19. [Clinical and biological characteristics of non-IgM lymphoplasmacytic lymphoma]. Yu Y; Xiong WJ; Chen JW; Jiao Y; Yan YT; Wang Q; Zou DH; Liu W; Liu HM; Lyu R; Qiu LG; Yi SH Zhonghua Xue Ye Xue Za Zhi; 2022 Jul; 43(7):568-574. PubMed ID: 36709134 [No Abstract] [Full Text] [Related]
20. Waldenstrom Macroglobulinemia/Lymphoplasmacytic Lymphoma Associated with Nephrotic Syndrome during Hemodialysis, Treated Successfully with Tirabrutinib. Sekiguchi Y; Nishimura Y; Kanda H; Kawamura M; Kobayashi K; Kobayashi H Intern Med; 2022 Aug; 61(16):2503-2508. PubMed ID: 35110483 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]